Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15 000 leukemia cases and 46 000 controls from the Childhood Cancer and Leukemia International Consortium
Authors:
- Philip J. LupoPhilip J. Lupo
- Tiffany M. ChambersTCTiffany M. Chambers
- Beth A. MuellerBMBeth A. Mueller
- Jacqueline ClavelJCJacqueline Clavel
- John D. DockertyJDJohn D. Dockerty
- David R. DoodyDDDavid R. Doody
- Friederike ErdmannFEFriederike Erdmann
- Sameera EzzatSESameera Ezzat
- Tommaso FilippiniTFTommaso Filippini
- Johnni HansenJHJohnni Hansen
- Julia E. HeckJHJulia E. Heck
- Claire Infante‐RivardCIClaire Infante‐Rivard
- 11 September 2023
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 154 (3) , 434-447
Abstract
Although recent studies have demonstrated associations between nonchromosomal birth defects and several pediatric cancers, less is known about their role on childhood leukemia susceptibility. Using data from the Childhood Cancer and Leukemia International Consortium, we evaluated associations between nonchromosomal birth defects and childhood leukemia. Pooling consortium data from 18 questionnaire‐based and three registry‐based case‐control studies across 13 countries, we used multivariable logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between a spectrum of birth defects and leukemia. Our analyses included acute lymphoblastic leukemia (ALL, n = 13 115) and acute myeloid leukemia (AML, n = 2120) cases, along with 46 172 controls. We used the false discovery rate to account for multiple comparisons. In the questionnaire‐based studies, the prevalence of birth defects was 5% among cases vs 4% in controls, whereas, in the registry‐based studies, the prevalence was 11% among cases vs 7% in controls. In pooled adjusted analyses, there were several notable associations, including (1) digestive system defects and ALL (OR = 2.70, 95% CI: 1.46‐4.98); (2) congenital anomalies of the heart and circulatory system and AML (OR = 2.86, 95% CI: 1.81‐4.52) and (3) nervous system defects and AML (OR = 4.23, 95% CI: 1.50‐11.89). Effect sizes were generally larger in registry‐based studies. Overall, our results could point to novel genetic and environmental factors associated with birth defects that could also increase leukemia susceptibility. Additionally, differences between questionnaire‐ and registry‐based studies point to the importance of complementary sources of birth defect phenotype data when exploring these associations.Keywords
Funding Information
- CHILDREN with CANCER UK
- U.S. Department of War (CA190214, W81XWH‐20‐1‐0567)
- U.S. Environmental Protection Agency (RD83451101)
- National Institutes of Health (R01CA249867, R01CA266253, R03CA272955, R01CA284531)
- Cancer Prevention and Research Institute of Texas (RP210064, RP160771)
This publication has 43 references indexed in Scilit:
- Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study groupBlood, 2014
- Cancer Risk in Children and Adolescents with Birth Defects: A Population-Based Cohort StudyPLOS ONE, 2013
- Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood CancerJAMA, 2013
- The Childhood Leukemia International ConsortiumCancer Epidemiology, 2013
- Cancer in Children with Nonchromosomal Birth DefectsThe Journal of Pediatrics, 2012
- Congenital anomaly and childhood cancer: A population‐based, record linkage studyPediatric Blood & Cancer, 2008
- Cancer Risk in Children with Birth Defects and in Their Families: A Population Based Cohort Study of 5.2 Million Children from Norway and SwedenCancer Epidemiology, Biomarkers & Prevention, 2008
- Congenital abnormalities and childhood cancerCancer, 2005
- The National Birth Defects Prevention StudyPublic Health Reports®, 2001
- Simultaneous Occurrence of Mongolism and LeukemiaA.M.A. Journal of Diseases of Children, 1957